Chronic Total Occlusions (CTO): 60 Second Insights
Published: 08 March 2018
-
Views:
2186
-
Likes:
7
-
Views:
2186
-
Likes:
7
-
Up Next
-
52sPart 2 | Session 1 Ajay Kirtane
-
1mPart 2 | Session 2 Simon Walsh
-
49sPart 2 | Session 3 Paul Knaapen
-
27sPart 2 | Session 4 Emmanouil Brilakis
-
1m 36sPart 2 | Session 5 Carlos Di Mario
-
55sPart 2 | Session 6 Patrick Serruys
-
55sPart 2 | Session 7 Gerald Werner
-
25sPart 3 | Session 1 Ajay Kirtane
-
46sPart 3 | Session 2 Simon Walsh
-
1mPart 3 | Session 3 Paul Knaapen
-
35sPart 3 | Session 4 Emmanouil Brilakis
-
1m 9sPart 3 | Session 5 Carlos Di Mario
-
57sPart 3 | Session 6 Patrick Serruys
-
1m 12sPart 3 | Session 7 Gerald Werner
-
46sPart 4 | Session 1 Ajay Kirtane
-
1m 6sPart 4 | Session 2 Simon Walsh
-
1m 7sPart 4 | Session 3 Paul Knaapen
-
46sPart 4 | Session 4 Emmanouil Brilakis
-
1m 11sPart 4 | Session 5 Patrick Serruys
-
1m 24sPart 4 | Session 6 Gerald Werner
-
38sPart 5 | Session 1 Ajay Kirtane
-
46sPart 5 | Session 2 Simon Walsh
-
55sPart 5 | Session 3 Paul Knaapen
-
41sPart 5 | Session 4 Emmanouil Birlakis
-
56sPart 5 | Session 5 Carlos Di Mario
-
50sPart 5 | Session 6 Patrick Serruys
-
47sPart 5 | Session 7 Gerald Werner
-
42sPart 6 | Session 1 Ajay Kirtane
-
1m 1sPart 6 | Session 2 Simon Walsh
-
1m 2sPart 6 | Session 3 Paul Knaapen
-
35sPart 6 | Session 4 Emmanouil Birkalis
-
40sPart 6 | Session 5 Carlos Di Mario
-
1m 18sPart 6 | Session 6 Patrick Serruys
-
1m 7sPart 6 | Session 7 Gerald Werner
-
57sPart 7 | Session 1 Ajay Kirtane
-
1m 15sPart 7 | Session 2 Simon Walsh
-
1m 5sPart 7 | Session 3 Paul Knaapen
-
49sPart 7 | Session 4 Emmanouil Birkalis
-
1m 25sPart 7 | Session 5 Carlos Di Mario
-
1m 36sPart 7 | Session 6 Patrick Serruys
-
1m 24sPart 7 | Session 7 Gerald Werner
-
45sPart 8 | Session 1 Ajay Kirtane
-
37sPart 8 | Session 2 Simon Walsh
-
1mPart 8 | Session 3 Paul Knaapen
-
37sPart 8 | Session 4 Emmanouil Birlakis
-
1m 4sPart 8 | Session 5 Carlos Di Mario
-
1m 5sPart 8 | Session 6 Patrick Serruys
-
1m 7sPart 8 | Session 7 Gerald Werner
-
48sPart 9 | Session 1 Ajay Kirtane
-
52sPart 9 | Session 2 Simon Walsh
-
1m 4sPart 9 | Session 3 Paul Knaappen
-
53sPart 9 | Session 4 Emmanouil Brilakis
-
1m 7sPart 9 | Session 5 Patrick Serruys
-
1m 18sPart 9 | Session 6 Carlos Di Mario
-
1m 7sPart 9 | Session 7 Gerald Werner
Overview
A series of 60-second interviews where Ajay Kirtane, Simon Walsh, Paul Knappen, Emmanouil Brilakis, Carlos Di Mario, Partick Serruys and Gerald Werner provide their thoughts on CTOs.
More from this programme
Part 1
Are CTOs important to the management of angina in your patients?
| 1 session | |
| Ajay Kirtane | Watch now |
Part 2
What trials are needed to advance the CTO field?
Part 3
What is your preferred imaging modality for CTOs?
Part 4
What is your preferred CTO wire strategy, and why?
Part 5
What is the biggest advance in CTO treatment in the past 5 years?
Part 6
What devices should be developed to further advance CTO management?
Part 7
The data for CTO is mixed, with clinical trials showing no clear benefit, should we keep on doing CTO's?
Part 8
Retrograde or anterograde? What is your preferred strategy?
Part 9
How would you recommend someone starts a CTO program?
Faculty Biographies
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…